IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease June 2, 2026 IMU has built the world’s largest immune dataset and can use a simple blood sample to measure over 100 million immune data points, providing precise actionable insights for patients and healthcare providers Proceeds from the latest round will support IMU’s operational expansion and development of clinical platform and infrastructure, alongside advancing the Company’s clinical programmes
Smartstream Launches Smart Agents for Back-Office Operations, Proven Across Tier 1 Pilots June 2, 2026 Key Facts Smart Agents is now widely available to Smart Reconciliations clients, covering bank reconciliations, cash breaks, settlement exceptions, and post-trade investigations — combining client institutional knowledge with Smartstream’s domain expertise to deliver value from day one. Pilot results demonstrate a 97% reduction in investigation time per exception, from 14 minutes manually to 30 seconds, with Tier 1 clients projecting 50–70% automation in year one. Smart Agents surfaces the steps requiring human action and executes everything else autonomously — including counterparty and internal communications, available in assistive and autonomous operating modes with human-in-the-loop oversight, full audit trail, step-by-step explainability, complete data privacy, and intelligence that compounds continuously over time.
ThetaRay Gamifies Financial Defense at Money20/20 Europe with a Compliance Twist on “Where’s Waldo” June 2, 2026 With “Spot The Money Mule”, ThetaRay unites Agentic AI and public education to disrupt criminal recruitment; pushing for an ecosystem-wide stand against illicit finance.
Blackstone Raises its Largest Asia Private Equity Fund at $13.1 Billion June 2, 2026 Oversubscribed Fund More than Doubles Capital Raised for Predecessor Vehicle
Interactive Brokers Integrates AI into Client Portfolios – Informed by Agentic Technology, Controlled by the Client June 1, 2026 Clients Can Research Stocks, Analyze Performance, and Generate Trade Instructions in Claude. The Client Approves Every Trade.
KBRA Releases Research – European Fibre ABS: From Build-out to Securitisation June 1, 2026 KBRA releases research examining how European fibre assets may fit within an ABS framework. The US fibre ABS market provides the clearest securitisation reference point, while European fibre financings offer useful context on operating performance and contractual revenue models. As of May 2026, KBRA had rated approximately $29.9 billion of US fibre ABS and rated [...]
Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience June 1, 2026 Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of CONTOUR®COMFORT pen needles, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601917225/en/ “With CONTOUR COMFORT pen needles, we [...]
Corient Completes Acquisitions of Stonehage Fleming and Stanhope Capital Group; Global Assets Surpass US$500 Billion June 1, 2026 Corient becomes the world’s largest non-bank wealth manager and multi-family office focused on serving ultra-high- and high-net-worth clients.
Autobrains and Uber to Launch Agentic AI Robotaxi Program in Munich built on NVIDIA DRIVE Hyperion June 1, 2026 Combining Uber’s mobility network, Autobrains’ Agentic AI, and NVIDIA DRIVE Hyperion Launching a Munich robotaxi service designed to scale into a fully autonomous fleet Creating an OEM-agnostic model for autonomous ride-hailing across vehicle platforms
AAHI’s SLA-SE Adjuvant Technology Powers Lilly’s Acquisition of Curevo’s Next-Generation Shingles Vaccine May 28, 2026 SLA-SE adjuvant validated as a superior vaccine technology to protect people from infectious disease without debilitating side effects